Clinicopathological significance of the expression of CD44v2 in colorectalcancer

Citation
K. Haruyama et al., Clinicopathological significance of the expression of CD44v2 in colorectalcancer, ANTICANC R, 19(5C), 1999, pp. 4421-4428
Citations number
26
Categorie Soggetti
Onconogenesis & Cancer Research
Journal title
ANTICANCER RESEARCH
ISSN journal
02507005 → ACNP
Volume
19
Issue
5C
Year of publication
1999
Pages
4421 - 4428
Database
ISI
SICI code
0250-7005(199909/10)19:5C<4421:CSOTEO>2.0.ZU;2-7
Abstract
Expression of CD44 valiant isoforms has been reported to be correlated with faster progression of neoplastic diseases metastasis ann reduced survival period In this study! the correlation between the expression of CD44v2 (v2) or CD44v6 (v6) and clinicopathological features was examined in Dukes B an d C colorectal cancer using immunohistochemistry. V6 expression was not cor related with any clinicopathological indices or-prognosis in either Dukes B or C. On the other hand, v2 expression was correlated significantly with r ecurrence rate and poorer prognosis in Dukes B colorectal cancer although t here was no correlation between v2 expression and prognosis in Dukes C pati ents. The results suggest that v2 is a candidate for a prognostic marker in Dukes B colorectal cancer. CD44v2 expression may be an indication for adop ting adjuvant chemotherapy in patients without lymph node metastasis.